Check out Pro
Top CompaniesRecent TradesCluster BuysSectorsBlog
Join the Insiderviz Pro waitlist
Aprea Therapeutics, Inc. (APRE)
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
6 Jun 2023
Seizinger Bernd R.
Director
Aprea Therapeutics, Inc.
(APRE)
26,325+62%
10,097
$3.66
$36,956.55
BUY
18 May 2022
Seizinger Bernd R.
Director
Aprea Therapeutics, Inc.
(APRE)
318,580+18%
50,000
$0.71
$35,500.00
BUY
18 May 2022
SCHADE CHRISTIAN S
Chairman & CEO, Director, Officer
Aprea Therapeutics, Inc.
(APRE)
292,616+14%
37,500
$0.64
$24,123.75
SELL
28 Feb 2022
Attar Eyal C.
SVP, Chief Medical Officer, Officer
Aprea Therapeutics, Inc.
(APRE)
47,000-43%
36,000
$1.73
$62,280.00
SELL
1 Dec 2021
Korbel Gregory Alan
SVP, Chief Business Officer, Officer
Aprea Therapeutics, Inc.
(APRE)
17,167-61%
27,500
$3.96
$108,900.00
SELL
1 Nov 2021
Korbel Gregory Alan
SVP, Chief Business Officer, Officer
Aprea Therapeutics, Inc.
(APRE)
17,167-61%
27,500
$5.00
$137,500.00
SELL
1 Oct 2021
Abrahmsen Lars B.
SVP, Chief Scientific Officer, Officer
Aprea Therapeutics, Inc.
(APRE)
19,000-72%
50,000
$4.89
$244,500.00
SELL
1 Oct 2021
Korbel Gregory Alan
SVP, Chief Business Officer, Officer
Aprea Therapeutics, Inc.
(APRE)
17,167-61%
27,500
$4.89
$134,475.00
SELL
20 Sep 2021
Abrahmsen Lars B.
SVP, Chief Scientific Officer, Officer
Aprea Therapeutics, Inc.
(APRE)
19,000-56%
25,000
$4.97
$124,249.99
SELL
20 Sep 2021
Korbel Gregory Alan
SVP, Chief Business Officer, Officer
Aprea Therapeutics, Inc.
(APRE)
17,167-65%
32,960
$4.97
$163,865.80
SELL
16 Sep 2021
Attar Eyal C.
SVP, Chief Medical Officer, Officer
Aprea Therapeutics, Inc.
(APRE)
83,000-16%
15,968
$4.68
$74,730.23
SELL
28 Dec 2020
Redmile Group, LLC
10% Owner
Aprea Therapeutics, Inc.
(APRE)
1,774,581-21%
500,000
$5.58
$2,791,290.00
SELL
5 Oct 2020
5AM Ventures IV, L.P.
Former 10% holder
Aprea Therapeutics, Inc.
(APRE)
138,497-55%
175,000
$25.30
$4,427,500.00
SELL
7 Jul 2020
KDev Investments AB
10% Owner
Aprea Therapeutics, Inc.
(APRE)
1,992,586-10%
241,703
$34.55
$8,350,838.50
SELL
16 Jun 2020
5AM Ventures IV, L.P.
10% Owner
Aprea Therapeutics, Inc.
(APRE)
1,823,192-7%
140,000
$33.30
$4,662,000.00
SELL
16 Jun 2020
ROCKLAGE SCOTT M
Director, 10% Owner
Aprea Therapeutics, Inc.
(APRE)
1,823,192-6%
120,164
$33.30
$4,001,461.00
SELL
11 Jun 2020
5AM Ventures IV, L.P.
10% Owner
Aprea Therapeutics, Inc.
(APRE)
1,938,549-11%
245,000
$28.75
$7,044,411.50
SELL
11 Jun 2020
ROCKLAGE SCOTT M
Director, 10% Owner
Aprea Therapeutics, Inc.
(APRE)
1,938,549-11%
245,000
$28.75
$7,044,411.50
SELL
19 May 2020
5AM Ventures IV, L.P.
10% Owner
Aprea Therapeutics, Inc.
(APRE)
2,173,748-10%
255,000
$35.15
$8,963,250.00
SELL
19 May 2020
ROCKLAGE SCOTT M
Director
Aprea Therapeutics, Inc.
(APRE)
2,173,748-10%
255,000
$35.15
$8,963,250.00
SELL
13 Apr 2020
KDev Investments AB
10% Owner
Aprea Therapeutics, Inc.
(APRE)
2,234,289-8%
210,548
$31.25
$6,579,625.00
BUY
7 Oct 2019
HENNEMAN JOHN B III
Director
Aprea Therapeutics, Inc.
(APRE)
5,000+100%
5,000
$15.00
$75,000.00
BUY
7 Oct 2019
Versant V Luxco S.a r.l.
10% Owner
Aprea Therapeutics, Inc.
(APRE)
333,333+100%
333,333
$15.00
$4,999,995.00
BUY
7 Oct 2019
5AM Ventures IV, L.P.
10% Owner
Aprea Therapeutics, Inc.
(APRE)
333,333+100%
333,333
$15.00
$4,999,995.00
BUY
7 Oct 2019
HealthCap VII, L.P.
10% Owner
Aprea Therapeutics, Inc.
(APRE)
2,366,104+12%
266,667
$15.00
$4,000,005.00
BUY
7 Oct 2019
Attar Eyal C.
SVP, Chief Medical Officer, Officer
Aprea Therapeutics, Inc.
(APRE)
200+200%
400
$15.00
$6,000.00
BUY
7 Oct 2019
Versant Vantage I, L.P.
10% Owner
Aprea Therapeutics, Inc.
(APRE)
333,333+100%
333,333
$15.00
$4,999,995.00
BUY
7 Oct 2019
Redmile Group, LLC
10% Owner
Aprea Therapeutics, Inc.
(APRE)
2,268,718+21%
400,000
$15.00
$6,000,000.00
BUY
7 Oct 2019
Christenson Johan
Director
Aprea Therapeutics, Inc.
(APRE)
2,366,104+12%
266,667
$15.00
$4,000,005.00
BUY
7 Oct 2019
Magni Guido
Director
Aprea Therapeutics, Inc.
(APRE)
6,500+100%
6,500
$15.00
$97,500.00
BUY
7 Oct 2019
Korbel Gregory Alan
VP of Business Dev't, Officer
Aprea Therapeutics, Inc.
(APRE)
500+100%
500
$15.00
$7,500.00
BUY
7 Oct 2019
Coiante Scott M
SVP, Chief Financial Officer, Officer
Aprea Therapeutics, Inc.
(APRE)
2,500+100%
2,500
$15.00
$37,500.00
BUY
7 Oct 2019
SCHADE CHRISTIAN S
President & CEO, Director, Officer
Aprea Therapeutics, Inc.
(APRE)
1,000+110%
11,000
$15.00
$165,000.00
Home
Top CompaniesForm ScreenerSectors
DisclaimersPrivacyTerms of Service
ContactBlogNewsletter